Ignite Creation Date:
2025-12-25 @ 5:06 AM
Ignite Modification Date:
2026-03-26 @ 7:49 PM
Study NCT ID:
NCT05663827
Status:
COMPLETED
Last Update Posted:
2024-03-05
First Post:
2022-11-23
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Ruxolitinib as add-on Therapy in Steroid-refractory Graft-vs-host Disease
Sponsor:
Yi-Lun Wang
Organization:
Organization Data
Organization:
Class:
OTHER
Study ID:
RSR-1123
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR_INVESTIGATOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None